Posts

• Airway Remodeling in Chronic Respiratory Disease: The Role of Fibroblasts and Epithelial Cells (23/10/2026)
• Alveolar Type I and Type II Cells in Preclinical Lung Models: Why Mixed Primary Populations Reflect Alveolar Biology More Accurately (23/09/2026)
• 3D bioprinted liver models for preclinical research (22/09/2026)
• How to Select the Right Non-Parenchymal Cells for Complex Liver Models (16/09/2026)
• Hepatic Stellate Cell Activation in Liver Fibrosis: In Vitro Models and the Case for Primary Human Cells (03/09/2026)
• Primary Human Hepatocyte Liver Spheroids for Drug Toxicity Testing in Preclinical Research (27/08/2026)
• Primary Human Hepatocytes in ADME Studies: In Vitro Models for Predictive Drug Metabolism (27/08/2026)
• Ex Vivo Human Skin Explants in Preclinical Research: Model Types, Applications and Tissue Requirements (27/08/2026)
• In Vitro MASLD and MASH Models: Selecting Primary Human Liver Cells for Metabolic Disease Research (21/07/2026)
• Translating NAMs into Practical Drug Discovery Workflows Using Human-Derived Models (11/05/2026)
• Primary Human Lung Cells in Disease Modeling and Drug Development (07/04/2026)
• Regulatory Access to Biospecimens in the European Union: Procurement, Collection & Compliance for Research (18/03/2026)
• New Approach Methodologies (NAMs) in Preclinical Research: Redefining Toxicology Without Animal Models (02/03/2026)
• Logistics and Cold Chain Challenges in Rapid Delivery of Human Biospecimens for Preclinical Research (12/02/2026)
• Quality‑Assured Human Biospecimens: From Collection to Preclinical Use (21/01/2026)
• Cryopreserved primary human liver cells: improving reproducibility and scalability in preclinical assays (18/12/2025)
• Biomarkers in human liver cell assays for in vitro preclinical safety testing (09/12/2025)
• Integrating Liver Non‑Parenchymal Cells into Preclinical Toxicology Models (26/11/2025)
• What Type of Cells Are Hepatocytes? Understanding Liver Epithelial Cells (11/02/2025)
• Types of hepatocytes: A comprehensive guide for researchers (28/01/2025)
• Guide for hepatocyte ballooning: Causes and steatosis comparison (23/01/2025)
• Primary human hepatocytes vs. cell lines in research (23/01/2025)
• Isolation and culture of human primary hepatocytes (07/11/2024)
• How are HepG2 cells different from primary hepatocytes? (21/10/2024)
• Predictive genotoxicity and mutagenicity of drugs using liver-on-a-chip (08/10/2024)
• In vitro lung models for translational research in respiratory diseases (23/09/2024)
• In vitro skin models as an alternative to cosmetic animal testing (13/09/2024)
• How to culture liver organoids (06/09/2024)
• What non-parenchymal cell types are present in the liver? (12/08/2024)
• Organ-on-a-chip: a new paradigm for drug screening and disease modeling (24/07/2024)
• Experts talks: CRO services to navigate the complexities of in vitro research (10/07/2024)
• Experts talks: in vitro cellular models to shape the future of biomedical research (19/06/2024)
• In vitro models for MAFLD: a 2024 update (12/06/2024)
• Bioprinted in vitro liver models to propel clinical advances in drug development (27/05/2024)
• Predict Drug-Induced Liver Injury (DILI) with Primary Human Hepatocyte Spheroids (10/05/2024)
• 3D liver models for drug testing (15/04/2024)
• Experts talks: In vitro liver models for reliable predictions in preclinical stages (03/04/2024)
• Organoids vs Spheroids: 3 important differences (12/03/2024)
• 5 reasons to include Stellate Cells in your fibrotic liver model (27/02/2024)
• Experts talks: Tissue sourcing services to reduce research challenges (15/02/2024)
• Exploring the pros and cons of diverse tissue formats for research (31/01/2024)
• How can Liver Sinusoidal Endothelial Cells help you upgrade your research? (24/01/2024)
• Are you including Kupffer Cells in your hepatic models? (15/12/2023)
• New nomenclature for liver disease (NASH and NAFLD vs MASH and MASLD) (06/12/2023)
• Tips to work with primary hepatocytes (22/11/2023)
• Suspension vs. plateable hepatocytes, the importance of a good timing (13/11/2023)
• Why should you be using primary hepatocytes? (26/10/2023)
• Non-Parenchymal Cells: The Significant 30% (16/10/2023)
• Human Tissue Samples (04/09/2023)